ABERRANT MIRNA EXPRESSION IN PACLITAXEL-SPARED LUNG ADENOCARCINOMA-INITIATING CELLS FROM THE A549 CELL LINE

被引：1
|
作者：
Chen, Z. T. [1 ]
Lin, S. [1 ]
Sun, J. G. [1 ]
Ma, H. [1 ]
Yao, Q. [1 ]
Zhang, A. -M. [1 ]
Peng, L. N. [1 ]
机构：
[1] Third Mil Med Univ, Inst Canc, Xinqiao Hosp, Chongqing, Peoples R China
来源：
EUROPEAN JOURNAL OF CANCER | 2014年 / 50卷
关键词：
D O I：
10.1016/j.ejca.2014.03.038
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
OP0020
引用
收藏
页码：E7 / E7
页数：1
相关论文
共 50 条
  • [1] Aberrant microRNAs Expression in CD133+/CD326+ Human Lung Adenocarcinoma Initiating Cells from A549
    Lin, Sheng
    Sun, Jian-guo
    Wu, Jing-bo
    Long, Hai-xia
    Zhu, Cong-hui
    Xiang, Tong
    Ma, Hu
    Zhao, Zhong-quan
    Yao, Quan
    Zhang, An-mei
    Zhu, Bo
    Chen, Zheng-tang
    MOLECULES AND CELLS, 2012, 33 (03) : 277 - 283
  • [2] Monitoring microRNAs Using a Molecular Beacon in CD133+/CD338+ Human Lung Adenocarcinoma-initiating A549 Cells
    Yao, Quan
    Sun, Jian-Guo
    Ma, Hu
    Zhang, An-Mei
    Lin, Sheng
    Zhu, Cong-Hui
    Zhang, Tao
    Chen, Zheng-Tang
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2014, 15 (01) : 161 - 166
  • [3] Effects of paclitaxel on cell proliferation and apoptosis and its mechanism in human lung adenocarcinoma A549 cells
    Baoan Gao1
    2Department of Respiratory Medicine
    3Department of Respiratory Medicine
    4Department of Cardiology
    JournalofNanjingMedicalUniversity, 2006, (06) : 360 - 364
  • [4] Sp1 Upregulates Survivin Expression in Adenocarcinoma of Lung Cell Line A549
    Chen, Yuqing
    Wang, Xiaojing
    Li, Wei
    Zhang, Hailong
    Zhao, Chengling
    Li, Yan
    Wang, Zhenhuan
    Chen, Changjie
    ANATOMICAL RECORD-ADVANCES IN INTEGRATIVE ANATOMY AND EVOLUTIONARY BIOLOGY, 2011, 294 (05): : 774 - 780
  • [5] Antitumor Activity of Acriflavine in Lung Adenocarcinoma Cell Line A549
    Lee, Chia-Jen
    Yue, Chia-Herng
    Lin, Yu-Jie
    Lin, Yu-Yu
    Kao, Shao-Hsuan
    Liu, Jer-Yuh
    Chen, Yieng-How
    ANTICANCER RESEARCH, 2014, 34 (11) : 6467 - 6472
  • [6] Comparative proteomic analysis of paclitaxel sensitive A549 lung adenocarcinoma cell line and its resistant counterpart A549-Taxol
    Qiang-ling Sun
    Hui-fang Sha
    Xiao-hua Yang
    Guo-liang Bao
    Jing Lu
    Yin-yin Xie
    Journal of Cancer Research and Clinical Oncology, 2011, 137 : 521 - 532
  • [7] Comparative proteomic analysis of paclitaxel sensitive A549 lung adenocarcinoma cell line and its resistant counterpart A549-Taxol
    Sun, Qiang-ling
    Sha, Hui-fang
    Yang, Xiao-hua
    Bao, Guo-liang
    Lu, Jing
    Xie, Yin-yin
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2011, 137 (03) : 521 - 532
  • [8] KANK1 regulates paclitaxel resistance in lung adenocarcinoma A549 cells
    Pu, Junyi
    Shen, Jianfeng
    Zhong, Zihua
    Yanling, Ma
    Gao, Jie
    ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY, 2020, 48 (01) : 639 - 647
  • [9] Proapoptotic lipid nanovesicles: Synergism with paclitaxel in human lung adenocarcinoma A549 cells
    Joshi, Nitin
    Shanmugam, Thanigaivel
    Kaviratna, Anubhav
    Banerjee, Rinti
    JOURNAL OF CONTROLLED RELEASE, 2011, 156 (03) : 413 - 420
  • [10] Gene expression profiling of cancer stem cell in human lung adenocarcinoma A549 cells
    Dong-Cheol Seo
    Ji-Min Sung
    Hee-Jung Cho
    Hee Yi
    Kun-Ho Seo
    In-Soo Choi
    Dong-Ku Kim
    Jin-Suk Kim
    Abd El-Aty AM
    Ho-Chul Shin
    Molecular Cancer, 6
12345